최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of inorganic biochemistry, v.224, 2021년, pp.111592 -
Nam, Geewoo (Corresponding author.) , Suh, Jong-Min , Yi, Yelim , Lim, Mi Hee
Abstract Alzheimer's disease (AD) presents a complex pathology entangling numerous pathological factors, including amyloid-β (Aβ), metal ions, and reactive oxygen species (ROS). Increasing evidence reveals pathological connections among these distinct components in AD. For instance, the a...
Chem. Rev. Savelieff 119 1221 2019 10.1021/acs.chemrev.8b00138 Development of multifunctional molecules as potential therapeutic candidates for Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis in the last decade
Science Hardy 256 184 1992 10.1126/science.1566067 Alzheimer's disease: the amyloid cascade hypothesis
Science Selkoe 365 540 2019 10.1126/science.aay5188 Early network dysfunction in Alzheimer's disease
Chem. Rev. Kepp 112 5193 2012 10.1021/cr300009x Bioinorganic chemistry of Alzheimer’s disease
J. NeuroImmune Pharmacol. Muhammad 14 278 2019 10.1007/s11481-018-9824-3 Melatonin rescue oxidative stress-mediated neuroinflammation/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model
Biochim. Biophys. Acta Mol. Cell Biol. Lipids Naudí 1862 485 2017 10.1016/j.bbalip.2017.02.001 Region-specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system
Nat. Cell Biol. Herrero-Mendez 11 747 2009 10.1038/ncb1881 The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1
FEBS Lett. Stefanatos 592 743 2018 10.1002/1873-3468.12902 The role of mitochondrial ROS in the aging brain
Biochemistry Nam 59 15 2020 10.1021/acs.biochem.9b00775 Synaptic copper, amyloid-β, and neurotransmitters in Alzheimer’s disease
Chem. Lett. Nam 48 951 2019 10.1246/cl.190281 Intertwined pathologies of amyloid-β and metal ions in Alzheimer’s disease: metal-amyloid-β
Acc. Chem. Res. Faller 47 2252 2014 10.1021/ar400293h Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles
Dalton Trans. Atrián-Blasco 46 12750 2017 10.1039/C7DT01344B Mutual interference of Cu and Zn ions in Alzheimer’s disease: perspectives at the molecular level
Coord. Chem. Rev. Atrián-Blasco 371 38 2018 10.1016/j.ccr.2018.04.007 Cu and Zn coordination to amyloid peptides: from fascinating chemistry to debated pathological relevance
Coord. Chem. Rev. Zawisza 256 2297 2012 10.1016/j.ccr.2012.03.012 Affinity of copper and zinc ions to proteins and peptides related to neurodegenerative conditions (Aβ, APP, α-synuclein, PrP)
ACS Chem. Biol. Savelieff 8 856 2013 10.1021/cb400080f Untangling amyloid-β, tau, and metals in Alzheimer's disease
Angew. Chem. Int. Ed. Zou 40 2274 2001 10.1002/1521-3773(20010618)40:12<2274::AID-ANIE2274>3.0.CO;2-5 Cu2+ inhibits the aggregation of amyloid β-peptide(1-42) in vitro
J. Biol. Chem. Yoshiike 276 32293 2001 10.1074/jbc.M010706200 New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity
J. Biol. Chem. Pedersen 286 26952 2011 10.1074/jbc.M111.220863 Cu(II) mediates kinetically distinct, non-amyloidogenic aggregation of amyloid-β peptides
Angew. Chem. Int. Ed. Jun 46 3959 2007 10.1002/anie.200700318 The aggregated state of amyloid-β peptide in vitro depends on Cu2+ ion concentration
Coord. Chem. Rev. Kepp 351 127 2017 10.1016/j.ccr.2017.05.007 Alzheimer’s disease: how metal ions define β-amyloid function
Nat. Rev. Drug Discov. Ashburn 3 673 2004 10.1038/nrd1468 Drug repositioning: identifying and developing new uses for existing drugs
Am. J. Psychiatry Rovner 146 350 1989 10.1176/ajp.146.3.350 Depression and Alzheimer's disease
Biol. Psychiatry Lyketsos 52 243 2002 10.1016/S0006-3223(02)01348-3 Depression in Alzheimer’s disease: overview and treatment
Neurol. Ther. Burke 8 325 2019 10.1007/s40120-019-00148-5 Diagnosing and treating depression in patients with Alzheimer’s disease
J. Neuropsychiatry Clin. Neurosci. Lyketsos 9 556 1997 10.1176/jnp.9.4.556 Major and minor depression in Alzheimer’s disease: prevalence and impact
J. Neuropsychiatry Clin. Neurosci. Payne 10 440 1998 10.1176/jnp.10.4.440 Relationship of cognitive and functional impairment to depressive features in Alzheimer’s disease and other dementias
Arch. Gen. Psychiatry Ownby 63 530 2006 10.1001/archpsyc.63.5.530 Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis
Brain Res. Rev. Frisardi 67 344 2011 10.1016/j.brainresrev.2011.04.003 Late-life depression and Alzheimer's disease: the glutamatergic system inside of this mirror relationship
Eur. J. Pharmacol. Caraci 626 64 2010 10.1016/j.ejphar.2009.10.022 Depression and Alzheimer's disease: neurobiological links and common pharmacological targets
Brain Behav. Immun. Santos 55 151 2016 10.1016/j.bbi.2015.11.011 Microglial dysfunction connects depression and Alzheimer’s disease
Experientia Pletscher 47 4 1991 10.1007/BF02041242 The discovery of antidepressants: a winding path
Indian J. Psychiatry Ramachandraih 53 180 2011 10.4103/0019-5545.82567 Antidepressants: from MAOIs to SSRIs and more
Neurotoxicology Youdim 25 243 2004 10.1016/S0161-813X(03)00103-7 Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation
Eur. J. Clin. Pharmacol. Palm 3 82 1971 10.1007/BF00619299 Quantitation of irreversible inhibition of monoamine oxidase in man
J. Am. Chem. Soc. Lee 136 299 2014 10.1021/ja409801p Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease
Proc. Natl. Acad. Sci. U. S. A. Choi 107 21990 2010 10.1073/pnas.1006091107 Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity
J. Am. Chem. Soc. Derrick 137 14785 2015 10.1021/jacs.5b10043 A redox-active, compact molecule for cross-linking amyloidogenic peptides into nontoxic, off-pathway aggregates: in vitro and in vivo efficacy and molecular mechanisms
J. Am. Chem. Soc. Hindo 131 16663 2009 10.1021/ja907045h Small molecule modulators of copper-induced Aβ aggregation
Chem. Eur. J. Lee 23 2706 2017 10.1002/chem.201605401 Structural and mechanistic insights into development of chemical tools to control individual and inter-related pathological features in Alzheimer's disease
Chem. Sci. Beck 6 1879 2015 10.1039/C4SC03239J A rationally designed small molecule for identifying an in vivo link between metal-amyloid-β complexes and the pathogenesis of Alzheimer’s disease
J. Am. Chem. Soc. Barclay 106 2479 1984 10.1021/ja00320a066 Autoxidation of micelles and model membranes. Quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants
Biochemistry Maheshwari 49 10371 2010 10.1021/bi101249p Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro
Synthesis Kawase 46 455 2014 10.1055/s-0033-1340484 Reductive alkylation of hydrazine derivatives with α-picoline-borane and its applications to the syntheses of useful compounds related to active pharmaceutical ingredients
Chem. Sci. Yi 12 2456 2021 10.1039/D0SC04366D Impact of sphingosine and acetylsphigosines on the aggregaiton and toxicity of metal-free and metal-treated amyloid-β
Chem. Commun. Yi 55 5847 2019 10.1039/C9CC01005J Tunable regulatory activities of 1,10-phenanthroline derivatives towards acid sphingomyelinase and Zn(II)-amyloid-β
ACS Chem. Neurosci. Han 9 800 2018 10.1021/acschemneuro.7b00454 Tuning structures and properties for developing novel chemical tools toward distinct pathogenic elements in Alzheimer’s disease
Chem. Eur. J. Kang 23 1645 2017 10.1002/chem.201604751 An iridium(III) complex as a photoactivatable tool for oxidation of amyloidogenic peptides with subsequent modulation of peptide aggregation
Biochemistry Smith 46 2881 2007 10.1021/bi0620961 Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-β peptide
J. Biol. Chem. Raman 280 16157 2005 10.1074/jbc.M500309200 Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid β peptide
Proc. Natl. Acad. Sci. U. S. A. Han 117 5160 2020 10.1073/pnas.1916944117 Mechanistic approaches for chemically modifying the coordination sphere of copper-amyloid-β complexes
Inorg. Chem. Front. Kim 7 4222 2020 10.1039/D0QI00791A Reactivities of cyclam derivatives with metal-amyloid-β
Free Radic. Biol. Med. Forrest 16 675 1994 10.1016/0891-5849(94)90182-1 Oxidative stress-induced apoptosis prevented by Trolox
J. Am. Chem. Soc. Kim 142 8183 2020 10.1021/jacs.9b13100 Minimalistic principles for designing small molecules with multiple reactivities against pathological factors in dementia
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.